HOUSE OF COMMONS OF CANADA
35th PARLIAMENT, 1st SESSION

EVIDENCE

Sub-Committee
on

HIV / AIDS

of the Standing Committee on Health

Chairman: Bernard Patry

Meeting No. 20

Thursday, December 7, 1995

ORDER OF THE DAY:

Roundtable on compassionate access to experimental drugs

WITNESSES:

Canadian Association for HIV Research:

Dr. Mark Wainberg.

COCQ-sida:

Lise Pineault, Coordinator.

Community AIDS Treatment Information Exchange:

Dierdre MacLean, Community Liaison Coordinator.

Department of Health:

Beth Pieterson, Chief, Submission and Information Policy Division;

Dr. Tomasz Uscinowicz, Manager, Clinical Trials and Special Access Program, Drugs Directorate.

Individual Presentation:

Dr. Ken Logue;

Dr. Doug McFadden.

Nova Scotia AIDS Coalition:

James Shedden, Men's Project Coordinator.

Ottawa General Hospital:

Dr. Bill Cameron, Clinical Trials Network.

Pharmaceutical Manufacturers Association of Canada:

Dr. Sophia Fourie, Vice-President, Medical and Regulatory Affairs, Pharmacea and Upjohn Inc.;

Dr. Michael Levy, Vice-President, Medical Sciences, Glaxo Wellcome.